BioAge Labs Inc. (BIOA)
NASDAQ: BIOA
· Real-Time Price · USD
4.70
-0.04 (-0.84%)
At close: Sep 03, 2025, 3:59 PM
-0.84% (1D)
| Bid | 4.63 |
| Market Cap | 168.32M |
| Revenue (ttm) | 3.86M |
| Net Income (ttm) | -79.03M |
| EPS (ttm) | -6.81 |
| PE Ratio (ttm) | -0.69 |
| Forward PE | -1.85 |
| Analyst | Hold |
| Ask | 4.94 |
| Volume | 988 |
| Avg. Volume (20D) | 196,901 |
| Open | 4.78 |
| Previous Close | 4.74 |
| Day's Range | 4.70 - 4.78 |
| 52-Week Range | 2.88 - 26.62 |
| Beta | 1.45 |
About BIOA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BIOA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BIOA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
BioAge Labs Inc. is scheduled to release its earnings on
Nov 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
8 months ago
+4.88%
BioAge Labs shares are trading higher after the co...
Unlock content with
Pro Subscription
8 months ago
-76.85%
BioAdge Labs shares are trading lower after Jefferies downgraded the stock from Buy to Hold and Citigroup downgraded the stock from Buy to Neutral. Additionally, both firms cut their price target on the stock to $7.
4 weeks ago · fool.com
BioAge Labs (BIOA) Q2 Revenue Hits $2.4MBioAge Labs (BIOA) Q2 Revenue Hits $2.4M